Literature DB >> 7993630

Structural basis of the different gating kinetics of fetal and adult acetylcholine receptors.

C Bouzat1, N Bren, S M Sine.   

Abstract

Structure-function studies have identified key functional motifs in the acetylcholine receptor, including residues that contribute to the ion channel and to the ligand-binding sites. Little is known, however, about determinants of channel gating kinetics. To identify structural correlates of gating, we examined the structural basis of the fetal-to-adult decrease in channel open time conferred by the presence of the epsilon subunit in place of the gamma subunit. By constructing chimeras composed of segments of the epsilon and gamma subunits, we show that the main determinant of this kinetic change is a 30 residue segment of a predicted amphipathic helix located between transmembrane domains M3 and M4. Further subdividing the amphipathic helix revealed that either multiple residues or its overall conformation confers this regulation of channel kinetics. We also show that L440 and M442, conserved residues within M4 of the gamma subunit, contribute to long duration openings characteristic of the fetal receptor.

Mesh:

Substances:

Year:  1994        PMID: 7993630     DOI: 10.1016/0896-6273(94)90424-3

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  52 in total

Review 1.  Inherited and experimentally induced changes in gating kinetics of muscle nicotinic acetylcholine receptor.

Authors:  C Bouzat; F J Barrantes
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

2.  Subunit-selective contribution to channel gating of the M4 domain of the nicotinic receptor.

Authors:  Cecilia Bouzat; Fernanda Gumilar; María del Carmen Esandi; Steven M Sine
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

3.  Structural elements near the C-terminus are responsible for changes in nicotinic receptor gating kinetics following patch excision.

Authors:  G Akk; J H Steinbach
Journal:  J Physiol       Date:  2000-09-15       Impact factor: 5.182

4.  Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation.

Authors:  H L Wang; A Auerbach; N Bren; K Ohno; A G Engel; S M Sine
Journal:  J Gen Physiol       Date:  1997-06       Impact factor: 4.086

5.  Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit.

Authors:  M Milone; H L Wang; K Ohno; T Fukudome; J N Pruitt; N Bren; S M Sine; A G Engel
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

6.  Spontaneous muscle action potentials fail to develop without fetal-type acetylcholine receptors.

Authors:  Masazumi Takahashi; Tai Kubo; Akira Mizoguchi; C George Carlson; Katsuaki Endo; Katsunori Ohnishi
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

7.  Single-channel and structural foundations of neuronal α7 acetylcholine receptor potentiation.

Authors:  Corrie J B daCosta; Chris R Free; Jeremías Corradi; Cecilia Bouzat; Steven M Sine
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

8.  The M4 Transmembrane α-Helix Contributes Differently to Both the Maturation and Function of Two Prokaryotic Pentameric Ligand-gated Ion Channels.

Authors:  Camille M Hénault; Peter F Juranka; John E Baenziger
Journal:  J Biol Chem       Date:  2015-08-28       Impact factor: 5.157

9.  Key roles of hydrophobic rings of TM2 in gating of the alpha9alpha10 nicotinic cholinergic receptor.

Authors:  Paola V Plazas; María J De Rosa; María E Gomez-Casati; Miguel Verbitsky; Noelia Weisstaub; Eleonora Katz; Cecilia Bouzat; Ana Belén Elgoyhen
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

10.  Potentiation of a neuronal nicotinic receptor via pseudo-agonist site.

Authors:  Simone Mazzaferro; Isabel Bermudez; Steven M Sine
Journal:  Cell Mol Life Sci       Date:  2019-01-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.